Profile data is unavailable for this security.
About the company
Jacobson Pharma Corporation Ltd is an investment holding company principally engaged in the manufacturing and sale of generic drugs. The Company operates its business through two segments. The Generic Drugs segment is engaged in the development, manufacture and distribution of a host of off-patent medicines for various therapeutic use. The Branded Healthcare segment is engaged in the development, manufactures and distributes branded medicines, proprietary Chinese medicines and health and wellness products. Currently the activities of two segments in this regard are primarily carried out in Hong Kong.
- Revenue in HKD (TTM)1.47bn
- Net income in HKD210.24m
- Incorporated--
- Employees1.72k
- LocationJacobson Pharma Corporation LtdUnit 2313-18, 23/F,Tower 1, Millennium2681 Hong KongHKG
- Phone+852 22672298
- Websitehttp://www.jacobsonpharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hbm Holdings Ltd | 562.02m | 165.78m | 979.73m | 158.00 | 5.68 | 0.9833 | 5.00 | 1.74 | 0.2253 | 0.2253 | 0.7623 | 1.30 | 0.3258 | 3.96 | 16.67 | 3,175,272.00 | 9.59 | -54.61 | 13.25 | -66.04 | 95.57 | 97.81 | 29.42 | -400.28 | 3.44 | 8.14 | 0.3502 | -- | 120.13 | 127.06 | 116.61 | -- | -12.62 | -- |
| Jbm (Healthcare) Ltd | 648.42m | 130.46m | 1.16bn | 279.00 | 9.53 | 1.21 | 6.31 | 1.79 | 0.1479 | 0.1479 | 0.7338 | 1.17 | 0.4645 | 4.25 | 5.98 | 2,324,068.00 | 9.83 | 4.38 | 12.04 | 5.52 | 52.14 | 46.47 | 21.16 | 12.69 | 1.25 | 89.68 | 0.1155 | 32.98 | 24.62 | 16.09 | 128.51 | 19.99 | 2.26 | -- |
| SinoMab Bioscience Ltd | 2.18m | -214.45m | 1.28bn | 214.00 | -- | 4.29 | -- | 586.93 | -0.2059 | -0.2059 | 0.0021 | 0.2725 | 0.0023 | -- | -- | 10,122.40 | -22.83 | -24.62 | -29.11 | -27.72 | 26.80 | -- | -9,853.75 | -4,451.74 | -- | -81.79 | 0.6339 | -- | -- | -- | 14.45 | -- | 106.81 | -- |
| Essex Bio-Technology Ltd | 1.62bn | 262.89m | 1.51bn | 1.46k | 5.93 | 0.7519 | 4.77 | 0.9358 | 0.4499 | 0.4499 | 2.73 | 3.55 | 0.5587 | 2.62 | 2.73 | 1,093,064.00 | 9.07 | 11.20 | 12.10 | 14.73 | 89.78 | 86.01 | 16.24 | 19.77 | 1.61 | -- | 0.1397 | 16.16 | 29.51 | 7.72 | 22.11 | 3.56 | 7.29 | 7.39 |
| Jacobson Pharma Corporation Ltd | 1.47bn | 210.24m | 1.60bn | 1.72k | 7.31 | 0.6678 | 4.55 | 1.09 | 0.1095 | 0.1391 | 0.7644 | 1.20 | 0.3311 | 2.47 | 6.37 | 851,885.10 | 4.74 | 4.30 | 5.76 | 5.57 | 42.27 | 41.25 | 14.32 | 13.73 | 1.73 | 5.33 | 0.2382 | 40.62 | 15.79 | -0.1401 | 1.31 | -3.05 | 24.06 | 4.10 |
| Cryofocus Medtech Shanghai Co Ltd | 44.59m | -114.14m | 1.67bn | 370.00 | -- | 13.17 | -- | 37.38 | -0.4774 | -0.4774 | 0.1865 | 0.5293 | 0.1881 | 0.418 | 4,369.58 | 113,752.20 | -51.79 | -- | -66.30 | -- | 76.35 | -- | -275.28 | -- | 2.06 | -80.68 | 0.2303 | -- | 50.83 | -- | 13.13 | -- | -- | -- |
| Ascletis Pharma Inc | 10.84m | -277.65m | 1.80bn | 219.00 | -- | 0.7957 | -- | 165.88 | -0.2674 | -0.2674 | 0.0104 | 2.31 | 0.0041 | 1.34 | 3.58 | 49,491.39 | -10.47 | -6.43 | -10.85 | -6.64 | -125.17 | 35.67 | -2,561.69 | -243.38 | 24.31 | -- | 0.004 | -- | 4.63 | -19.39 | 54.04 | -- | -20.44 | -- |
| Dawnrays Pharmaceutical (Holdings) Ltd | 1.16bn | 604.88m | 1.85bn | 1.18k | 3.05 | 0.5257 | 2.70 | 1.59 | 0.4027 | 0.4027 | 0.7714 | 2.34 | 0.2838 | 2.05 | 6.17 | 1,013,738.00 | 14.74 | 9.89 | 17.79 | 12.49 | 56.58 | 56.69 | 51.92 | 27.89 | 3.04 | -- | 0.0544 | 35.33 | -9.90 | 3.94 | -8.95 | 1.41 | 63.92 | 2.00 |
| VIVA Biotech Holdings | 2.14bn | -341.59k | 1.90bn | 2.04k | -- | 0.4684 | 7.61 | 0.888 | -0.0054 | -0.0054 | 1.04 | 1.90 | 0.2603 | 5.26 | 5.18 | 1,031,897.00 | 0.4017 | -1.39 | 0.5601 | -1.68 | 33.66 | 34.81 | 1.54 | -5.44 | 1.46 | 3.19 | 0.2884 | -- | -9.42 | 59.31 | 78.03 | -- | 31.98 | -- |
| Golden Throat Holdings Group Co Ltd | 1.08bn | 281.67m | 2.36bn | 860.00 | 8.37 | 1.71 | 7.29 | 2.18 | 0.381 | 0.381 | 1.46 | 1.86 | 0.4994 | 3.23 | 4.07 | 1,243,848.00 | 13.01 | 11.00 | 19.26 | 15.63 | 72.29 | 72.79 | 26.06 | 24.67 | 1.93 | 37.74 | 0.2814 | 83.15 | -3.09 | 6.73 | -11.04 | 19.61 | -32.13 | 38.94 |
Data as of Nov 22 2024. Currency figures normalised to Jacobson Pharma Corporation Ltd's reporting currency: Hong Kong Dollar HKD
0.46%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 07 Nov 2024 | 8.29m | 0.41% |
| Dimensional Fund Advisors Ltd.as of 31 Aug 2024 | 629.68k | 0.03% |
| Bessemer Investment Management LLCas of 31 Jul 2024 | 205.92k | 0.01% |
| Lazard Asset Management LLCas of 31 Oct 2024 | 126.00k | 0.01% |
| DFA Australia Ltd.as of 31 May 2023 | 65.24k | 0.00% |
| Nomura Asset Management Co., Ltd.as of 31 Oct 2024 | 4.31k | 0.00% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
